Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2024 Earnings Call Transcript February 27, 2025
Aurinia Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $0.01 EPS, expectations were $0.03.
Operator: Greetings, and welcome to the Aurinia Pharmaceuticals Fourth Quarter and Full-Year 2024 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder this...
